| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp | 10%+ Owner | $43.9M | Dec 12, 2023 | ||
| Baxter International Inc | 10%+ Owner | $3.33M | Jun 24, 2021 | ||
| Cheshire MD Holdings, LLC | 10%+ Owner | $3.17M | Jun 28, 2021 | ||
| Ronald E. Eibensteiner | Director | $320K | Jun 28, 2021 | ||
| John Joseph Barry | Vice President Of R&D | $56.8K | Mar 10, 2023 | ||
| Brian Niebur | Chief Financial Officer | $39.5K | Jan 13, 2022 | ||
| Laji Kattungal | Vice President Of Quality | $16K | Jan 13, 2022 | ||
| Mark T. Wagner | Director | $5.33K | Jun 28, 2021 | ||
| Peter Maag | Director | Dec 12, 2023 | |||
| James Michael Douglas | Chief Financial Officer | Dec 12, 2023 | |||
| William Burke | Director | Dec 12, 2023 | |||
| John L. Erb | Director | Dec 12, 2023 | |||
| Paul Buckman | Director | Dec 12, 2023 | |||
| Jeffrey James Ross | CHIEF EXECUTIVE OFFICER, Director | Dec 12, 2023 | |||
| Lisa Wipperman Heine | Director | Dec 12, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|